questionsmedicales.fr
Environnement et santé publique
Santé publique
Méthodes épidémiologiques
Méthodologie en recherche épidémiologique
Méthode en double aveugle
Méthode en double aveugle : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
2
Méthodes de recherche
Biais
Évaluation clinique
Essais cliniques
Médicaments
Interventions thérapeutiques
Symptômes
2
Symptômes
Évaluation des symptômes
Biais d'observation
Échelles d'évaluation
Mesure des symptômes
Évaluation clinique
Prévention
2
Prévention
Vaccins
Essais cliniques
Interventions préventives
Placebo
Essais contrôlés
Traitements
2
Traitements médicaux
Essais cliniques
Interventions chirurgicales
Biais
Efficacité des traitements
Essais contrôlés
Complications
2
Complications
Effets indésirables
Évaluation clinique
Rapports d'effets indésirables
Évaluation des complications
Essais cliniques
Facteurs de risque
2
Facteurs de risque
Contrôle des variables
Essais cliniques
Randomisation
Caractéristiques des participants
Essais contrôlés
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Méthode en double aveugle : Questions médicales les plus fréquentes",
"headline": "Méthode en double aveugle : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Méthode en double aveugle : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-13",
"dateModified": "2025-04-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Méthode en double aveugle"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Méthodologie en recherche épidémiologique",
"url": "https://questionsmedicales.fr/mesh/D015340",
"about": {
"@type": "MedicalCondition",
"name": "Méthodologie en recherche épidémiologique",
"code": {
"@type": "MedicalCode",
"code": "D015340",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.445"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Méthode en double aveugle",
"alternateName": "Double-Blind Method",
"code": {
"@type": "MedicalCode",
"code": "D004311",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Hiroyoshi Yajima",
"url": "https://questionsmedicales.fr/author/Hiroyoshi%20Yajima",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Miho Takayama",
"url": "https://questionsmedicales.fr/author/Miho%20Takayama",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Judith M Schlaeger",
"url": "https://questionsmedicales.fr/author/Judith%20M%20Schlaeger",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Nobuari Takakura",
"url": "https://questionsmedicales.fr/author/Nobuari%20Takakura",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Ted J Kaptchuk",
"url": "https://questionsmedicales.fr/author/Ted%20J%20Kaptchuk",
"affiliation": {
"@type": "Organization",
"name": "Program in Placebo Studies, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Application of Graphic Design with Computer Graphics and Image Processing: Taking Packaging Design of Agricultural Products as an Example.",
"datePublished": "2022-06-02",
"url": "https://questionsmedicales.fr/article/35693271",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/6554371"
}
},
{
"@type": "ScholarlyArticle",
"name": "Visualizing the invisible: aortopulmonary window diagnosis enhanced by 3D computer graphics.",
"datePublished": "2024-09-19",
"url": "https://questionsmedicales.fr/article/39297341",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1510/mmcts.2024.059"
}
},
{
"@type": "ScholarlyArticle",
"name": "Subjective perception of visual field defects using random noise-moving images in patients with glaucoma: A comparison of computer graphics and analog noises.",
"datePublished": "2024-05-20",
"url": "https://questionsmedicales.fr/article/38768185",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0303849"
}
},
{
"@type": "ScholarlyArticle",
"name": "Beading plot: a novel graphics for ranking interventions in network evidence.",
"datePublished": "2024-10-09",
"url": "https://questionsmedicales.fr/article/39385093",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12874-024-02355-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Design considerations for representing systems biology information with the Systems Biology Graphical Notation.",
"datePublished": "2022-07-04",
"url": "https://questionsmedicales.fr/article/35786424",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1515/jib-2022-0024"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Environnement et santé publique",
"item": "https://questionsmedicales.fr/mesh/D004778"
},
{
"@type": "ListItem",
"position": 3,
"name": "Santé publique",
"item": "https://questionsmedicales.fr/mesh/D011634"
},
{
"@type": "ListItem",
"position": 4,
"name": "Méthodes épidémiologiques",
"item": "https://questionsmedicales.fr/mesh/D004812"
},
{
"@type": "ListItem",
"position": 5,
"name": "Méthodologie en recherche épidémiologique",
"item": "https://questionsmedicales.fr/mesh/D015340"
},
{
"@type": "ListItem",
"position": 6,
"name": "Méthode en double aveugle",
"item": "https://questionsmedicales.fr/mesh/D004311"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Méthode en double aveugle - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Méthode en double aveugle",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Méthode en double aveugle",
"description": "Comment la méthode en double aveugle aide-t-elle au diagnostic ?\nQuels tests utilisent la méthode en double aveugle ?",
"url": "https://questionsmedicales.fr/mesh/D004311?mesh_terms=Computer+Graphics#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Méthode en double aveugle",
"description": "Les symptômes sont-ils évalués en double aveugle ?\nComment les symptômes sont-ils mesurés en double aveugle ?",
"url": "https://questionsmedicales.fr/mesh/D004311?mesh_terms=Computer+Graphics#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Méthode en double aveugle",
"description": "La méthode en double aveugle est-elle utilisée en prévention ?\nComment la prévention est-elle testée en double aveugle ?",
"url": "https://questionsmedicales.fr/mesh/D004311?mesh_terms=Computer+Graphics#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Méthode en double aveugle",
"description": "Quels traitements utilisent souvent la méthode en double aveugle ?\nPourquoi utiliser la méthode en double aveugle pour les traitements ?",
"url": "https://questionsmedicales.fr/mesh/D004311?mesh_terms=Computer+Graphics#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Méthode en double aveugle",
"description": "Les complications sont-elles prises en compte en double aveugle ?\nComment les complications sont-elles rapportées ?",
"url": "https://questionsmedicales.fr/mesh/D004311?mesh_terms=Computer+Graphics#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Méthode en double aveugle",
"description": "La méthode en double aveugle évalue-t-elle les facteurs de risque ?\nComment les facteurs de risque sont-ils pris en compte ?",
"url": "https://questionsmedicales.fr/mesh/D004311?mesh_terms=Computer+Graphics#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment la méthode en double aveugle aide-t-elle au diagnostic ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet d'évaluer l'efficacité d'un traitement sans biais d'observation."
}
},
{
"@type": "Question",
"name": "Quels tests utilisent la méthode en double aveugle ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des essais cliniques pour tester des médicaments ou des interventions."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils évalués en double aveugle ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, cela permet d'éviter que les attentes influencent les rapports de symptômes."
}
},
{
"@type": "Question",
"name": "Comment les symptômes sont-ils mesurés en double aveugle ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des échelles standardisées, sans que les évaluateurs sachent le traitement reçu."
}
},
{
"@type": "Question",
"name": "La méthode en double aveugle est-elle utilisée en prévention ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, pour évaluer l'efficacité des vaccins ou des interventions préventives."
}
},
{
"@type": "Question",
"name": "Comment la prévention est-elle testée en double aveugle ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "En comparant un groupe recevant le traitement préventif à un groupe placebo."
}
},
{
"@type": "Question",
"name": "Quels traitements utilisent souvent la méthode en double aveugle ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les essais de nouveaux médicaments, thérapies ou interventions chirurgicales."
}
},
{
"@type": "Question",
"name": "Pourquoi utiliser la méthode en double aveugle pour les traitements ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pour garantir que les résultats ne soient pas influencés par des attentes ou des biais."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prises en compte en double aveugle ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, pour évaluer les effets indésirables des traitements sans biais."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles rapportées ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des rapports standardisés, sans que les évaluateurs sachent le traitement reçu."
}
},
{
"@type": "Question",
"name": "La méthode en double aveugle évalue-t-elle les facteurs de risque ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Indirectement, en contrôlant les variables pour isoler l'effet du traitement."
}
},
{
"@type": "Question",
"name": "Comment les facteurs de risque sont-ils pris en compte ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "En randomisant les participants pour équilibrer les caractéristiques entre groupes."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 08/04/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Publications dans "Méthode en double aveugle" :
2 publications dans cette catégorie
Publications dans "Méthode en double aveugle" :
2 publications dans cette catégorie
Publications dans "Méthode en double aveugle" :
2 publications dans cette catégorie
Publications dans "Méthode en double aveugle" :
2 publications dans cette catégorie
Affiliations :
Program in Placebo Studies, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, USA.
Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.
Publications dans "Méthode en double aveugle" :
2 publications dans cette catégorie
Affiliations :
Department of Psychiatry and Behavioral Science, Stanford University, Stanford, CA, USA.
Publications dans "Méthode en double aveugle" :
2 publications dans cette catégorie
Publications dans "Méthode en double aveugle" :
2 publications dans cette catégorie
Publications dans "Méthode en double aveugle" :
2 publications dans cette catégorie
Publications dans "Méthode en double aveugle" :
2 publications dans cette catégorie
Publications dans "Méthode en double aveugle" :
2 publications dans cette catégorie
Publications dans "Méthode en double aveugle" :
2 publications dans cette catégorie
Affiliations :
NIZO Food Research B.V., 6718 ZB Ede, The Netherlands.
Publications dans "Méthode en double aveugle" :
2 publications dans cette catégorie
Affiliations :
NIZO Food Research B.V., 6718 ZB Ede, The Netherlands.
Publications dans "Méthode en double aveugle" :
2 publications dans cette catégorie
Affiliations :
Chinese EQUATOR Centre, Hong Kong Chinese Medicine Clinical Study Centre, Chinese Clinical Trial Registry (Hong Kong), School of Chinese Medicine, Hong Kong Baptist University, Kowloon, Hong Kong, People's Republic of China.
Publications dans "Méthode en double aveugle" :
1 publication dans cette catégorie
Affiliations :
Department of Emergency Medicine, Pavlodar Branch of NCJSC Semey Medical University, Pavlodar, Kazakhstan.
Publications dans "Méthode en double aveugle" :
1 publication dans cette catégorie
Affiliations :
Department of Emergency Medicine, Pavlodar Branch of NCJSC Semey Medical University, Pavlodar, Kazakhstan.
Publications dans "Méthode en double aveugle" :
1 publication dans cette catégorie
Affiliations :
Department of Surgery, Pavlodar Branch of NCJSC Semey Medical University, Pavlodar, Kazakhstan.
Publications dans "Méthode en double aveugle" :
1 publication dans cette catégorie
Affiliations :
Department of Health Services Management, Hiroshima International University, Hiroshima, Japan.
Publications dans "Méthode en double aveugle" :
1 publication dans cette catégorie
Affiliations :
Department of Surgery, Anesthesiology and Reanimatology, Semey Medical University, Semey, Kazakhstan.
Publications dans "Méthode en double aveugle" :
1 publication dans cette catégorie
Affiliations :
American University of Beirut, Beirut, Lebanon. tb14@aub.edu.lb.
Publications dans "Méthode en double aveugle" :
With development of economy, all industries have undergone earthshaking changes. Various new technologies are starting to be employed in all aspects of life, and graphic design is no exception. The us...
An aortopulmonary window is a rare disorder that occurs in 0.1-0.2% of all congenital disorders. Our patient was a 1-month-old boy weighing 4180 g. The patient had heart failure associated with an aor...
Random noise-moving images (noises) can make glaucoma patients with no subjective symptoms aware of visual field abnormalities. To explore this concept, we developed a noise using computer graphics (C...
We enrolled individuals with glaucoma (205 eyes), preperimetric glaucoma (PPG; 19 eyes), and normal eyes (35 eyes). For a CG noise, a series of still images was made by randomly selecting five monochr...
The detection rates (agreement and partial agreement) were 80.5% and 65.4% for the CG and analog noises, respectively, with CG noise showing a significantly higher detection rate in all glaucoma eyes ...
The CG noise is more effective than the analog noise in evaluating the subjective perception of visual field abnormalities in patients with glaucoma....
Network meta-analysis is developed to compare all available treatments; therefore it enriches evidence for clinical decision-making, offering insights into treatment effectiveness and safety when face...
Our team members developed a "beading plot" to summary probability of achieving the best treatment (P-best) and global metrics including surface under the cumulative ranking curve (SUCRA) and P-score....
Beading plot has been designed based on number line plot, which effectively displays collective metrics for each treatment across various outcomes. Order on the -axis is derived from ranking metrics l...
The beading plot is a valuable graphic that intuitively displays treatment rankings across diverse outcomes, enhancing reader-friendliness and aiding decision-making in complex network evidence scenar...
Visual representations are commonly used to explore, analyse, and communicate information and knowledge in systems biology and beyond. Such visualisations not only need to be accurate but should also ...
Motion Estimation (ME) and the two-dimensional (2D) discrete cosine transform (2D-DCT) are both computationally expensive parts of HEVC standard, therefore real-time performance of the HEVC may not be...
Network meta-analysis (NMA) is becoming a popular statistical tool for analyzing a network of evidence comparing more than two interventions. A particular advantage of NMA over pairwise meta-analysis ...
Current literature was searched, scrutinized, and provided direction for developing the novel graphical display. Ranking results were often found to be misinterpreted when presented alone and, to aid ...
Two new ranking visualizations were developed-the 'Litmus Rank-O-Gram' and the 'Radial SUCRA' plot-and embedded within a novel multipanel graphical display programmed within the MetaInsight applicatio...
This display was designed to improve the reporting, and facilitate a holistic understanding, of NMA results. We believe uptake of the display would lead to better understanding of complex results and ...
Augmented reality (AR) offers new ways to visualize information on-the-go. As noted in related work, AR graphics presented via optical see-through AR displays are particularly prone to color blending,...
Human language looms large in the emergence and evolution of graphic codes. Here, I argue that language not only acts as a strong constraint on graphic codes, but it is also a precondition for their e...
Photoacoustic tomography (PAT) provides high resolution optical images of tissue at depths of up to several centimetres. This modality has been of interest to researchers for at least 30 years and is ...